Improving cancer treatment imaging with advanced simulation techniques
GPU-based SPECT Reconstruction Using Reverse Monte Carlo Simulations
This study is working on a new software that helps create better 3D images for cancer treatment, so patients can receive safer and more effective therapies based on more accurate information about their radiation doses.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Massachusetts General Hospital NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-10740079 on NIH RePORTER |
What this research studies
This research focuses on enhancing the imaging techniques used in cancer treatment by developing a new software that utilizes GPU-based reverse Monte Carlo simulations for SPECT reconstruction. By accurately modeling the physical processes involved in radiation transport, the project aims to improve the quality of 3D imaging, which is crucial for determining the appropriate dosages and effectiveness of radiopharmaceutical treatments. Patients will benefit from more precise dosimetry, leading to safer and more effective cancer therapies. The approach involves advanced computational techniques to optimize the imaging process, making it faster and more reliable.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients undergoing treatment with radiopharmaceuticals for various types of cancer.
Not a fit: Patients not receiving radiopharmaceutical treatments or those with non-cancerous conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate cancer treatment dosages, improving patient outcomes and safety.
How similar studies have performed: Previous research has shown success in using Monte Carlo simulations for imaging improvements, indicating a promising potential for this novel approach.
Where this research is happening
Boston, United States
- Massachusetts General Hospital — Boston, United States (Active)
Researchers
- Principal investigator: Bertolet Reina, Alejandro — Massachusetts General Hospital
- Study coordinator: Bertolet Reina, Alejandro
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.